SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-17-040227
Filing Date
2017-06-19
Accepted
2017-06-19 17:29:33
Documents
2
Group Members
LANDON T. CLAYTHOMAS M. CLAY

Document Format Files

Seq Description Document Type Size
1 SC 13D a17-15439_1sc13d.htm SC 13D 126713
2 EX-99.1 a17-15439_1ex99d1.htm EX-99.1 10082
  Complete submission text file 0001104659-17-040227.txt   138703
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-31596 | Film No.: 17919334
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 MEMORIAL BOULEVARD SUITE 902 PROVIDENCE RI 02903
Business Address 10 MEMORIAL BOULEVARD SUITE 902 PROVIDENCE RI 02903 401-490-0700
East Hill Management Company, LLC (Filed by) CIK: 0001426610 (see all company filings)

IRS No.: 043523704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D